SAN DIEGO, July 25, 2024 (GLOBE NEWSWIRE) -- Women’s health innovator Evofem Biosciences, Inc. (“Evofem” or...
Appili, with a commercial-stage pipeline, has raised CAD $100M towards developing therapeutics for the global infectious disease and biodefense...
Evofem Signs Phexxi® License Agreement for Middle East with Pharma 1 PR Newswire SAN DIEGO, July 23, 2024 —...
Evofem Acquires SOLOSEC, an FDA-Approved Single-Dose Treatment for Bacterial Vaginosis and Trichomoniasis Aditxt, Inc. (“Aditxt”) (NASDAQ: ADTX...
Hello Alpha Partners with Evofem to Offer Phexxi® as a Hormone-Free Contraception Solution on its Platform for...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.